×
About 6,051 results

ALLMedicine™ Hidradenitis Suppurativa Center

Research & Reviews  2,731 results

JAAD Game Changers: Intralesional triamcinolone for flares of hidradenitis suppurativa ...
https://doi.org/10.1016/j.jaad.2021.04.011
Journal of the American Academy of Dermatology; Lake E

Apr 13th, 2021 - JAAD Game Changers: Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series.|2021|Lake E,|

Seven Years-Experience of adalimumab therapy for hidradenitis suppurativa in a real-lif...
https://doi.org/10.1080/09546634.2021.1914309
The Journal of Dermatological Treatment; Odorici G, Pacetti L et. al.

Apr 12th, 2021 - Hidradenitis Suppurativa (HS) often causes severe impairment of the quality of life of patients affected, as it is characterized by recurrent relapses of inflammation and predisposes to retractive scars, with severe alteration of anatomy of the af...

Insights from γ-Secretase: Functional Genetics of Hidradenitis Suppurativa.
https://doi.org/10.1016/j.jid.2021.01.023
The Journal of Investigative Dermatology; Vellaichamy G, Dimitrion P et. al.

Apr 10th, 2021 - Hidradenitis suppurativa (HS) is a chronic, relapsing, and remitting inflammatory disease of the skin with significant heritability and racial disposition. The pathogenesis of HS remains enigmatic, but occlusion of the terminal hair follicle and d...

Modified Posterior Arm Flap for Axillary Hidradenitis Suppurativa.
https://doi.org/10.1097/SAP.0000000000002819
Annals of Plastic Surgery; Thomson DR, Saltrese S et. al.

Apr 9th, 2021 - Hidradenitis suppurativa (HS) is a chronic, inflammatory condition of the apocrine sweat glands present in 1% to 4% of the adult population, with twice greater prevalence in females. Surgical excision is the criterion-standard treatment for advanc...

Comparing the Effectiveness and Safety Associated With Infliximab vs Infliximab-abda Th...
https://doi.org/10.1001/jamadermatol.2021.0220
JAMA Dermatology; Westerkam LL, Tackett KJ et. al.

Apr 7th, 2021 - Although limited effective and affordable treatment options exist for hidradenitis suppurativa, recent studies describe the effectiveness of a medical therapy, infliximab, for the treatment of hidradenitis suppurativa. Cost-saving biosimilar alter...

see more →

Guidelines  1 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 4th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

see more →

Clinicaltrials.gov  2,957 results

JAAD Game Changers: Intralesional triamcinolone for flares of hidradenitis suppurativa ...
https://doi.org/10.1016/j.jaad.2021.04.011
Journal of the American Academy of Dermatology; Lake E

Apr 13th, 2021 - JAAD Game Changers: Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series.|2021|Lake E,|

Seven Years-Experience of adalimumab therapy for hidradenitis suppurativa in a real-lif...
https://doi.org/10.1080/09546634.2021.1914309
The Journal of Dermatological Treatment; Odorici G, Pacetti L et. al.

Apr 12th, 2021 - Hidradenitis Suppurativa (HS) often causes severe impairment of the quality of life of patients affected, as it is characterized by recurrent relapses of inflammation and predisposes to retractive scars, with severe alteration of anatomy of the af...

Insights from γ-Secretase: Functional Genetics of Hidradenitis Suppurativa.
https://doi.org/10.1016/j.jid.2021.01.023
The Journal of Investigative Dermatology; Vellaichamy G, Dimitrion P et. al.

Apr 10th, 2021 - Hidradenitis suppurativa (HS) is a chronic, relapsing, and remitting inflammatory disease of the skin with significant heritability and racial disposition. The pathogenesis of HS remains enigmatic, but occlusion of the terminal hair follicle and d...

Modified Posterior Arm Flap for Axillary Hidradenitis Suppurativa.
https://doi.org/10.1097/SAP.0000000000002819
Annals of Plastic Surgery; Thomson DR, Saltrese S et. al.

Apr 9th, 2021 - Hidradenitis suppurativa (HS) is a chronic, inflammatory condition of the apocrine sweat glands present in 1% to 4% of the adult population, with twice greater prevalence in females. Surgical excision is the criterion-standard treatment for advanc...

Comparing the Effectiveness and Safety Associated With Infliximab vs Infliximab-abda Th...
https://doi.org/10.1001/jamadermatol.2021.0220
JAMA Dermatology; Westerkam LL, Tackett KJ et. al.

Apr 7th, 2021 - Although limited effective and affordable treatment options exist for hidradenitis suppurativa, recent studies describe the effectiveness of a medical therapy, infliximab, for the treatment of hidradenitis suppurativa. Cost-saving biosimilar alter...

see more →

News  269 results

New Analysis Eyes the Surgical Landscape for Hidradenitis Suppurativa
https://www.medscape.com/viewarticle/948026

Mar 23rd, 2021 - Among patients who undergo surgery for hidradenitis suppurativa (HS), wide excision and flap-based reconstruction are associated with lower postsurgical recurrence, yet these options should be balanced against potentially higher morbidity of exten...

Inflammatory Skin Diseases and CKD Risk: What’s the Link?
https://www.medscape.com/viewarticle/947916

Mar 22nd, 2021 - Takeaway Atopic eczema, psoriasis and hidradenitis suppurativa were weakly associated with chronic kidney disease (CKD), independent of obesity, cardiovascular morbidity or non-biologic nephrotoxic skin medications. No evidence supporting this ass...

Adalimumab Enhances Primary Wound Closure After HS Surgery
https://www.medscape.com/viewarticle/945207

Feb 2nd, 2021 - Delaying surgical reconstruction of fistula structures until after patients with hidradenitis suppurativa (HS) have been on adalimumab for a minimum of 6 months transforms primary wound closure into a highly attractive option, a pilot study sugges...

Oral JAK1 Inhibitor Shows Promise for Hidradenitis Suppurativa
https://www.medscape.com/viewarticle/944781

Jan 26th, 2021 - A once-daily oral selective Janus kinase 1 inhibitor demonstrated promising safety and efficacy for the treatment of moderate to severe hidradenitis suppurativa (HS) in a pair of small, randomized, phase 2 studies that established proof-of-concept...

Increased Hypothyroidism Risk Seen in Young Men With HS
https://www.staging.medscape.com/viewarticle/932882

Jun 23rd, 2020 - Young men with hidradenitis suppurativa are "surprisingly" at increased risk for hypothyroidism, Anna Figueiredo, MD, declared at the virtual annual meeting of the American Academy of Dermatology. The surprise about this finding from a large retro...

see more →

Patient Education  93 results see all →